BANC vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BANC exhibits mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. While earnings growth is strong (56.8% YoY) and profitability margins are high, low ROE (5.99%) and ROA (0.62%) suggest inefficient asset utilization. The stock trades below the analyst target of $23.14 but above the conservative Graham Number of $21.94, implying modest upside with moderate risk. Insider selling and a bearish technical trend temper otherwise positive growth and valuation signals.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BANC vs BRK-B: Head-to-Head Comparison
This page compares Banc of California, Inc. (BANC) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.